Update on the Clinical Use and Mechanisms of Action of IVIG in the Treatment of Autoimmune Neurological Disorders
نویسنده
چکیده
and genetic basis of various neuromuscular, demyelinating and neu-ronal disorders affecting muscle, nerves, or brain, and applying new therapeutic interventions via target-oriented control therapeutic clinical trials. He is the author or coauthor of more than 500 scientific papers or chapters in peer-reviewed journals. He has also edited 11 books and monographs and currently serves on the editorial board of several journals, including Brain, Neurology, BMC Neurology, and Neuromuscular Disorders. Dr. Dalakas also holds a patent on an im-munotoxin for the treatment of focal movement disorders. by a fellowship in neuromuscular diseases and a staff fellowship in neurovirology and neuroimmunology at NINDS.
منابع مشابه
Uses of intravenous immunoglobulin
Adjuvant high dose IVIgs are being used increasingly in a range of immune-mediated and auto-immune diseases. Although numerous immunomodulatory mechanisms have been suggested, the exact mechanisms of action are poorly understood. The efficacy of IVIg in certain diseases has been proven in clinical trials, in so far as IVIg is approved as the therapy of choice for Kawasaki syndrome and idiopathi...
متن کاملClinical Application and Functional Mechanisms of Intravenous Immunoglobulin: an Overview
Previous, Intravenous Immunoglobulin (IVIG) has been used for treatment of patients with immunodeficiency. However, recent studies have shown that IVIG is a suitable approach for treatment of inflammatory and autoimmune diseases. Although the exact mechanism of IVIG action is not well known, recent findings have demonstrated that IVIG impacts on expression and function of FC receptors of immuno...
متن کاملThree cases of systemic lupus erythematosus and review of the mechanisms concerning treatment with intravenous immunoglobulins (IVIG).
The systemic lupus erythematosus (SLE) is an autoimmune disorder with a broad array of clinical signs. In this research, we aimed to use intravenous immunoglobulins (IVIG) called intacglobin as monotherapy to manage an SLE in three patients. Laboratory investigations for SLE diagnosis were done, including the detection of anti-nuclear antibodies (ANA) and SLE confirmation by detecting high tite...
متن کاملTreatment of Neurological and Psychiatric Disorders with Deep Brain Stimulation Raising Hopes and Future Challenges
The technology of Neural Stimulation in recent years has become the focus of the research and treatment, although it has been around for many years. The potential use of stimulating the brain and nerves ranges from the spinal cord stimulation to the implantations of cochlear and bionic eyes with a large discrepancy between the clinical readiness for these various uses. Electrical high-frequency...
متن کاملO 16: Challenge in Diagnosis and Management of Autoimmune Encephalitis
The first description of an autoimmune encephalitis dates back to 1888, when Hermann Oppenheim described a patient with neurological symptoms but no underlying brain pathology. The field of autoimmune encephalitides associated with antibodies targeting cell-surface antigens is rapidly expanding and new antibodies are discovered frequently. Autoimmune encephalitis is a difficult clinical diagnos...
متن کاملO18: Autoimmune Encephalitis (Pathophysiology, Clinical Signs and Diagnos Tic Tests)
Autoimmune encephalitis is a difficult clinical diagnosis due to the similarities in the clini­cal, imaging and laboratory findings of many forms of autoimmune and infectious encephalitis. Autoimmune encephalitis involves several types: The first group includes the classic paraneo­plastic disorders associated with antibodies to intracellular antigens. The second group involves autoanti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010